GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galectin Therapeutics Inc (STU:PHPN) » Definitions » Future Policy Benefits

Galectin Therapeutics (STU:PHPN) Future Policy Benefits


View and export this data going back to 2014. Start your Free Trial

What is Galectin Therapeutics Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Galectin Therapeutics (STU:PHPN) Business Description

Traded in Other Exchanges
Address
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.